Sanofi to transfer 20 medicines and three plants to Cheplapharm

Sanofi is handing 20 older medicines to Greifswald-based specialist Cheplapharm, including the anticoagulant Lovenox/Clexane outside the US, together with three plants: Csanyikvölgy near Miskolc in Hungary with about 400 staff, Jurong in Singapore with about 100 and Ploërmel in France with about 65. In return Sanofi receives a 26.4% stake in Cheplapharm; further financial details are still to come. Staff transfer with their existing contracts and collective agreements, and according to Világgazdaság with a three-year employment guarantee at Miskolc — no job cuts or closures are planned. The products start moving across in the first quarter of 2027, with the plants following after employee consultation and regulatory approvals; everything is due to be completed by the third quarter of 2027 (Bionity, 16 Sep 2026; announced on 14 Sep 2026 according to Világgazdaság, 1 Oct 2026).